Prevention of ventilator-associated pneumonia in intensive care units: an international online survey

Table 4 VAP prevention: measurements, as reported by ICU doctors

Measurements	Weighted estimates for Europe (respondents from 16 countries with >=10 replies)			Other respondents (61 countries)
	N=1281			N=449
	%*	95% CI		N	%	95% CI
Measurement of compliance at least once a year
Hand hygiene recommendations	57	54	60	265	60	54	64
Systematic daily interruption of sedation and weaning protocol	28	24	33	102	23	19	27
Oral care with chlorhexidine	27	23	30	126	28	24	32
“In my ICU, there is a written definition of VAP for data collection”	50	47	54	286	64	59	68
YES- European guidelines	26	23	29	37	8	6	11
YES- CDC guidelines	12	10	15	206	46	41	51
“In my ICU, we count and record, routinely…” (% saying “yes”)
VAP	55	51	58	287	64	59	68
Intubation-days	81	78	84	364	81	74	85
Intubated patients	90	88	92	367	82	78	85
Please provide, if possible, the following data for your ICU - for part or all 2011 (% providing data)
VAP/ 1000 ventilation-days	20	17	22	113	25	21	29
Mean duration of intubation for intubated patients (days)	27	25	30	148	33	29	37
Proportion of intubated patients	38	35	41	178	40	35	44
“Clinical staff in my ICU is aware of VAP-related measures, and their trends” (% agree strongly / agree)	53	50	56	298	66	62	71

ISSN: 2047-2994